Clinical significance of residual disease during treatment in childhood acute myeloid leukaemia.
Coustan-Smith E, Ribeiro RC, Rubnitz JE, Razzouk BI, Pui CH, Pounds S, Andreansky M, Behm FG, Raimondi SC, Shurtleff SA, Downing JR, Campana D.
Coustan-Smith E, et al. Among authors: ribeiro rc.
Br J Haematol. 2003 Oct;123(2):243-52. doi: 10.1046/j.1365-2141.2003.04610.x.
Br J Haematol. 2003.
PMID: 14531905
Free article.